A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)

Condition:   Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions:   Drug: Bedaquiline;   Drug: Clarithromycin;   Drug: Ethambutol;   Drug: Rifampicin;   Drug: Rifabutin Sponsor:   Janssen Pharmaceutical K.K. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials